Spauwen PJ, van Eupen MG, Kohler S, et al
Its oral bioavailability is achieved by incorporating the absorption enhancer SNAC (Sodium N-[8-(2-hydroxybenzoyl)amino]caprylate), which works through two mechanisms: (1) temporarily raising the local pH in the stomach to reduce pepsin-induced degradation of the peptide drug, and (2) forming hydrophobic ion pairs (HIP) with the peptide drug, improving its membrane permeability
To verify the knockdown of ARL8B and TBC1D9B, cells were lysed in a buffer containing 1% Igepal, 1 M Tris pH 8, 150 mM NaCl, and protease inhibitors cComplete mini, along with phosphatase inhibitor cocktails 2 and 3
State-Level Changes: Some states may consider pilot programs to study the long-term cost-effectiveness of covering these drugs
Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study